We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Adaptable Contrast Media Improves MRI Diagnostics

By MedImaging International staff writers
Posted on 12 Dec 2018
Print article
Image: Xenon filled vesicles provide higher contrast MRI scans than conventional contrast agents (Photo courtesy of Barth van Rossum / FMP).
Image: Xenon filled vesicles provide higher contrast MRI scans than conventional contrast agents (Photo courtesy of Barth van Rossum / FMP).
An adaptable protein structure that absorbs dissolved xenon in a self-regulating way allows for higher quality magnetic resonance imaging (MRI) scans with less contrast medium, claims a new study.

Developed by researchers at Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP; Berlin, Germany) and the California Institute of Technology (Caltech; Pasadena, USA), the new contrast media is based on nanometric hollow protein structures produced by bacteria in order to regulate flotation depth, similar to a miniaturized swim bladder in fish. These so-called "gas vesicles" have a porous wall structure through which xenon gas can flow in and out, allowing them to elastically adjust their influence on the measured xenon.

Unlike conventional contrast media, the gas vesicles always absorb a fixed portion of the xenon present in the environment. This characteristic can be taken advantage of in MRI diagnostics, because more xenon gas must be used in order to obtain better images. While the concentration of a conventional contrast medium would need to be adjusted in order to achieve a change in signal for all xenon atoms, the gas vesicles automatically fill up with more xenon when this is offered.

As much more xenon is absorbed into the vesicles than with conventional contrast media, the image contrast is many times higher than the background noise, and image quality is significantly improved, allowing identification of disease markers that occur in relatively low concentrations. In animal studies, the researchers were able to produce MRI images with particle concentrations one million times lower than those of the contrast media currently employed. The study was published in the November 2018 issue of ACS Nano.

“We need new, improved methods, in which as little contrast medium as possible influences as much of the signal-transmitting substance as possible, typically water,” said senior author Leif Schroeder, PhD, director of the molecular imaging group at FMP. “They act like a kind of balloon, to which an external pump is attached. If the balloon is inflated by xenon atoms flowing into the gas vesicle its size does not change, but the pressure does increase, similar to a bicycle tire tube.”

Hyperpolarization of the nuclei of noble gases (usually using lasers) aligns them so that they become visible on an MRI scan. To detect specific cellular disease markers, they need to be bound to them for a short time. Gases used for medical imaging purposes include helium (He), argon (Ar), krypton (Kr), and xenon (Xe). The hyperpolarized spin state exists at very low spin temperatures, which leads to high magnetization of the spin ensemble, resulting in very high nuclear magnetic resonance signal intensity, which returns to thermal equilibrium by depolarization.

Related Links:
Leibniz-Forschungsinstitut für Molekulare Pharmakologie
California Institute of Technology

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Breast Imaging Workstation
SecurView
New
Thyroid Shield
Standard Thyroid Shield
New
Ultrasound Needle Guide
Ultra-Pro II

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The Cinematic Reality app enables interaction with realistic renderings of human anatomy (Photo courtesy of Siemens)

AR Application Turns Medical Scans Into Holograms for Assistance in Surgical Planning

Siemens Healthineers (Erlangen, Germany) has launched an app designed for Apple Vision Pro that allows users including surgeons, medical students, or patients to view immersive, interactive holograms of... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.